Itron (NASDAQ:ITRI - Get Free Report) had its target price boosted by equities research analysts at Roth Mkm from $125.00 to $130.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a "buy" rating on the scientific and technical instruments company's stock. Roth Mkm's price objective would suggest a potential upside of 16.27% from the company's current price.
ITRI has been the subject of several other reports. Oppenheimer lifted their price target on Itron from $120.00 to $124.00 and gave the company an "outperform" rating in a research report on Friday. Robert W. Baird boosted their target price on shares of Itron from $123.00 to $132.00 and gave the company an "outperform" rating in a research note on Friday. BNP Paribas assumed coverage on shares of Itron in a report on Thursday, September 5th. They set an "outperform" rating and a $133.00 price target on the stock. Guggenheim upgraded shares of Itron from a "neutral" rating to a "buy" rating and set a $130.00 price objective for the company in a research report on Thursday, July 11th. Finally, Piper Sandler increased their target price on shares of Itron from $110.00 to $119.00 and gave the stock a "neutral" rating in a research note on Friday. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Itron currently has an average rating of "Moderate Buy" and a consensus price target of $123.50.
Check Out Our Latest Analysis on ITRI
Itron Stock Up 0.0 %
NASDAQ ITRI traded up $0.05 on Friday, hitting $111.81. The stock had a trading volume of 963,729 shares, compared to its average volume of 521,076. The business's fifty day moving average price is $103.68 and its 200 day moving average price is $102.41. The stock has a market cap of $5.03 billion, a price-to-earnings ratio of 27.56, a price-to-earnings-growth ratio of 0.87 and a beta of 1.47. The company has a debt-to-equity ratio of 0.98, a current ratio of 3.16 and a quick ratio of 2.61. Itron has a 52-week low of $58.88 and a 52-week high of $116.39.
Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.71. The company had revenue of $615.46 million for the quarter, compared to the consensus estimate of $596.41 million. Itron had a net margin of 7.98% and a return on equity of 16.42%. Itron's revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.98 EPS. Equities research analysts anticipate that Itron will post 4.58 earnings per share for the current year.
Insider Activity
In other Itron news, SVP Donald L. Reeves III sold 4,210 shares of the company's stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $101.00, for a total value of $425,210.00. Following the sale, the senior vice president now owns 16,269 shares of the company's stock, valued at approximately $1,643,169. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Thomas Deitrich sold 887 shares of the business's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $102.15, for a total value of $90,607.05. Following the completion of the transaction, the chief executive officer now owns 205,276 shares of the company's stock, valued at $20,968,943.40. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Donald L. Reeves III sold 4,210 shares of the firm's stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $101.00, for a total transaction of $425,210.00. Following the sale, the senior vice president now owns 16,269 shares in the company, valued at approximately $1,643,169. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,276 shares of company stock worth $4,515,846 in the last 90 days. 1.45% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Hexagon Capital Partners LLC boosted its position in shares of Itron by 85.6% in the second quarter. Hexagon Capital Partners LLC now owns 271 shares of the scientific and technical instruments company's stock worth $27,000 after acquiring an additional 125 shares during the last quarter. Quarry LP grew its stake in shares of Itron by 53.0% during the 2nd quarter. Quarry LP now owns 352 shares of the scientific and technical instruments company's stock valued at $35,000 after buying an additional 122 shares during the period. GAMMA Investing LLC increased its holdings in shares of Itron by 46.6% during the 2nd quarter. GAMMA Investing LLC now owns 720 shares of the scientific and technical instruments company's stock worth $71,000 after buying an additional 229 shares during the last quarter. Farther Finance Advisors LLC grew its position in Itron by 21.7% during the third quarter. Farther Finance Advisors LLC now owns 724 shares of the scientific and technical instruments company's stock valued at $77,000 after acquiring an additional 129 shares during the period. Finally, CWM LLC increased its stake in Itron by 315.6% during the second quarter. CWM LLC now owns 881 shares of the scientific and technical instruments company's stock worth $87,000 after acquiring an additional 669 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company's stock.
Itron Company Profile
(
Get Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Articles
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.